These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 27368746)

  • 21. Powder Flow Testing: Judicious Choice of Test Methods.
    Tay JYS; Liew CV; Heng PWS
    AAPS PharmSciTech; 2017 Jul; 18(5):1843-1854. PubMed ID: 27844415
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improvement of flow and bulk density of pharmaceutical powders using surface modification.
    Jallo LJ; Ghoroi C; Gurumurthy L; Patel U; Davé RN
    Int J Pharm; 2012 Feb; 423(2):213-25. PubMed ID: 22197769
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Real-time image-based investigation of spheronization and drying phenomena using different pellet formulations.
    Burggraeve A; Sandler N; Heinämäki J; Räikkönen H; Remon JP; Vervaet C; De Beer T; Yliruusi J
    Eur J Pharm Sci; 2011 Dec; 44(5):635-42. PubMed ID: 22033152
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of preparation method on compactability of paracetamol granules and agglomerates.
    Fichtner F; Rasmuson AC; Alander EM; Alderborn G
    Int J Pharm; 2007 May; 336(1):148-58. PubMed ID: 17196775
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Properties of microcrystalline cellulose and powder cellulose after extrusion/spheronization as studied by fourier transform Raman spectroscopy and environmental scanning electron microscopy.
    Fechner PM; Wartewig S; Füting M; Heilmann A; Neubert RH; Kleinebudde P
    AAPS PharmSci; 2003 Nov; 5(4):E31. PubMed ID: 15198519
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Theophylline formulation by supercritical antisolvents.
    Roy C; Vega-González A; Subra-Paternault P
    Int J Pharm; 2007 Oct; 343(1-2):79-89. PubMed ID: 17582714
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Critical evaluation of root causes of the reduced compactability after roll compaction/dry granulation.
    Mosig J; Kleinebudde P
    J Pharm Sci; 2015 Mar; 104(3):1108-18. PubMed ID: 25558976
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Entrainment of lactose inhalation powders: a study using laser diffraction.
    Watling CP; Elliott JA; Cameron RE
    Eur J Pharm Sci; 2010 Jul; 40(4):352-8. PubMed ID: 20417708
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimised process and formulation conditions for extended release dry polymer powder-coated pellets.
    Terebesi I; Bodmeier R
    Eur J Pharm Biopharm; 2010 May; 75(1):63-70. PubMed ID: 20079833
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Crystal coating via spray drying to improve powder tabletability.
    Vanhoorne V; Peeters E; Van Snick B; Remon JP; Vervaet C
    Eur J Pharm Biopharm; 2014 Nov; 88(3):939-44. PubMed ID: 25445306
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlating particle hardness with powder compaction performance.
    Cao X; Morganti M; Hancock BC; Masterson VM
    J Pharm Sci; 2010 Oct; 99(10):4307-16. PubMed ID: 20310023
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of processing parameters and formulation factors on the drug release from tablets powder-coated with Eudragit L 100-55.
    Sauer D; Zheng W; Coots LB; McGinity JW
    Eur J Pharm Biopharm; 2007 Sep; 67(2):464-75. PubMed ID: 17451929
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of a new dispersion technique for assessing triboelectric charging of powders.
    Zafar U; Alfano F; Ghadiri M
    Int J Pharm; 2018 May; 543(1-2):151-159. PubMed ID: 29601973
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Miniaturization of powder dissolution measurement and estimation of particle size.
    Avdeef A; Tsinman K; Tsinman O; Sun N; Voloboy D
    Chem Biodivers; 2009 Nov; 6(11):1796-811. PubMed ID: 19937817
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The influence of mechanical processing of dry powder inhaler carriers on drug aerosolization performance.
    Young PM; Chan HK; Chiou H; Edge S; Tee TH; Traini D
    J Pharm Sci; 2007 May; 96(5):1331-41. PubMed ID: 17455362
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of a laser diffraction method for the determination of the particle size of aerosolised powder formulations.
    Marriott C; MacRitchie HB; Zeng XM; Martin GP
    Int J Pharm; 2006 Dec; 326(1-2):39-49. PubMed ID: 16942848
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of particle shape of active pharmaceutical ingredients prepared by fluidized-bed jet-milling on cohesiveness.
    Fukunaka T; Sawaguchi K; Golman B; Shinohara K
    J Pharm Sci; 2005 May; 94(5):1004-12. PubMed ID: 15793798
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of the lactose grade within dry powder formulations of fluticasone propionate and terbutaline sulphate.
    Le VN; Bierend H; Robins E; Steckel H; Flament MP
    Int J Pharm; 2012 Jan; 422(1-2):75-82. PubMed ID: 22036653
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Particle morphology influence on mechanical and biocompatibility properties of injection molded Ti alloy powder.
    Gülsoy HÖ; Gülsoy N; Calışıcı R
    Biomed Mater Eng; 2014; 24(5):1861-73. PubMed ID: 25201399
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Properties of drug-containing spherical pellets produced by a hot-melt extrusion and spheronization process.
    Young CR; Koleng JJ; McGinity JW
    J Microencapsul; 2003; 20(5):613-25. PubMed ID: 12909545
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.